Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra for Non-convulsive Status Epilepticus
NCT00603135Phase 2Withdrawn
- Sponsor
- University Hospital Basel
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levetiracetam in status epilepticus (SE), sponsored by University Hospital Basel. Primary endpoint: Clinical and/or electroencephalographic cessation of status epilepticus. Planned start Jan 2008; status: withdrawn.
02
Drugs
levetiracetam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT00603135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603135.